Alzheimer's disease (AD) is the most frequent cause of dementia, where the abnormal
accumulation of beta-amyloid (Aβ) and tau lead to neurodegeneration as well as loss of …

Debate exists regarding differences in the prevalence of Alzheimer disease (AD) in African
Americans and Hispanics in the United States, with some evidence suggesting that the …

Background Racial and ethnic minoritized groups are disproportionately at risk for
Alzheimer's Disease (AD), but are not sufficiently recruited in AD neuroimaging research in …

The effect of race on cognitive test performance in the evaluation of Alzheimer's disease
(AD) remains controversial. One factor that may contribute substantially to differences in …

Research on racial differences in Alzheimer disease (AD) dementia has increased in recent
years. Older African American individuals bear a disproportionate burden of AD and …

Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging
population and society as a whole. With the numbers of people with ADRDs predicted to rise …

Black Americans are disproportionately affected by dementia. To expand our understanding
of mechanisms of this disparity, we look to Alzheimer's disease (AD) biomarkers. In this …

Importance Racial differences in molecular biomarkers for Alzheimer disease may suggest
race-dependent biological mechanisms. Objective To ascertain whether there are racial …

This study reviews the published literature on racial and ethnic disparities among people
with Alzheimer's disease (AD) and related dementias in the United States. To identify …

Abstract Background African Americans have been reported to have a higher prevalence of
Alzheimer's disease (AD) than Caucasians, but etiology-specific AD biomarkers have not …